A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2.
Allergy
; 77(1): 243-257, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34496033
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccines, Virus-Like Particle
/
COVID-19
Limits:
Animals
/
Humans
Language:
En
Journal:
Allergy
Year:
2022
Type:
Article
Affiliation country:
Switzerland